Cargando…
FDA reports recall of Innova COVID-19 antigen rapid qualitative test
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233592/ http://dx.doi.org/10.1007/s40278-021-97802-1 |
Ejemplares similares
-
FDA remote evaluation of drug manufacturing during COVID-19
Publicado: (2021) -
Health Canada: risk of accidental poisoning from COVID-19 rapid antigen test kits
Publicado: (2022) -
FDA and CDC recommend resuming use of Janssen COVID-19 vaccine
Publicado: (2021) -
Certain Emerade adrenaline auto-injector pens being recalled in UK
Publicado: (2020) -
NICE COVID-19 rapid guidelines
Publicado: (2021)